Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
Abstract Background Liver fibrosis is a wound-healing response to chronic injury, featuring with excess accumulation of extracellular matrix secreted by the activated hepatic stellate cells (HSC). Disulfiram (DSF), also known as Antabuse, has been used for the treatment of alcohol addiction and subs...
Saved in:
Main Authors: | Xiao-Mei Yang (Author), Zheng Wu (Author), Xiaoqi Wang (Author), Yaoqi Zhou (Author), Lei Zhu (Author), Dongxue Li (Author), Hui-Zhen Nie (Author), Ya-Hui Wang (Author), Jun Li (Author), Xueyun Ma (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
by: Shiyun Pu, et al.
Published: (2021) -
Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
by: Man Wang, et al.
Published: (2022) -
Yao medicine Amydrium hainanense suppresses hepatic fibrosis by repressing hepatic stellate cell activation via STAT3 signaling
by: Bingmin Wu, et al.
Published: (2022) -
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
by: Song Wei, et al.
Published: (2019) -
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
by: Hans-Theo eSchon, et al.
Published: (2016)